Abstract: Slide Presentations |

The value of autofluorescence bronchoscopy in the pre-operative staging of lung cancer FREE TO VIEW

Georg Borkenhagen, MD; Cornelius Kortsik, MD; Andreas Budahn, *
Author and Funding Information

St. Hildegardis-Krankenhaus, Mainz, Germany


Chest. 2004;126(4_MeetingAbstracts):707S. doi:10.1378/chest.126.4_MeetingAbstracts.707S-a
Text Size: A A A
Published online


PURPOSE:  Autofluorescence bronchoscopy (AFB) is an established method for detection of pre-/early malignant lesions. Many studies have shown an increased detection rate in risk groups when autofluorescence was combined with white light bronchoscopy (WLB). The aim of this study is to determine whether the routine application of AFB in the pre-operative diagnostic of lung cancer gives relevant additional information regarding further therapy especially about anatomic operability or synchronous existence of pre-/early malignant changes.

METHODS:  Since 2002 every patient planned for operative treatment underwent an AFB with Storz D-Light AF after completion of pre-operative staging. During AFB biopsies were only taken from suspicious regions reported as normal in WLB.

RESULTS:  Until now 77 patients were investigated, 55 supicious sites were detected in AF-modus. Relevant additional information was obtained in two cases. In one case we found a synchronous Carcinoma in Situ in the contralateral lung resulting in photodynamic therapy (PDT) following operation. In the other case a wider extension of the diagnosed NSCLC was demonstrated with AFB leading to planned pneumonectomy instead of lobe resection.

CONCLUSION:  Until now the rate of additional information detected by AFB relevant for further therapy is 2 out of 77 cases. Therefore AFB has become a regular part in our pre-operative diagnostic of lung cancer.

CLINICAL IMPLICATIONS:  Although the rate of detected pre-/early malignant changes is not as high as in preceding studies, AFB is useful in the pre-operative diagnostic of lung cancer. We think this study is an argument in favour of the application of AFB in this special risk group.

DISCLOSURE:  A. Budahn, None.

Monday, October 25, 2004

10:30 AM- 12:15 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543